TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Sanofi AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
120,599
|
101,439
|
111,730 |
Financial expenses |
14
|
126
|
47 |
Earnings before taxes |
3,429
|
4,932
|
5,869 |
EBITDA |
3,485
|
5,051
|
6,445 |
Total assets |
70,028
|
50,008
|
58,259 |
Current assets |
69,349
|
49,351
|
58,247 |
Current liabilities |
56,375
|
35,140
|
37,272 |
Equity capital |
11,859
|
13,079
|
19,106 |
- share capital |
237
|
236
|
257 |
Employees (average) |
122
|
144
|
154 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
16.9%
|
26.2%
|
32.8% |
Turnover per employee |
989
|
704
|
726 |
Profit as a percentage of turnover |
2.8%
|
4.9%
|
5.3% |
Return on assets (ROA) |
4.9%
|
10.1%
|
10.2% |
Current ratio |
123.0%
|
140.4%
|
156.3% |
Return on equity (ROE) |
28.9%
|
37.7%
|
30.7% |
Change turnover |
18,865
|
-1,241
|
12,047 |
Change turnover % |
19%
|
-1%
|
12% |
Chg. No. of employees |
-22
|
-10
|
3 |
Chg. No. of employees % |
-15%
|
-6%
|
2% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.